PT3340975T - Formulação para o tratamento de acne - Google Patents

Formulação para o tratamento de acne

Info

Publication number
PT3340975T
PT3340975T PT167570183T PT16757018T PT3340975T PT 3340975 T PT3340975 T PT 3340975T PT 167570183 T PT167570183 T PT 167570183T PT 16757018 T PT16757018 T PT 16757018T PT 3340975 T PT3340975 T PT 3340975T
Authority
PT
Portugal
Prior art keywords
acne
formulation
treatment
Prior art date
Application number
PT167570183T
Other languages
English (en)
Inventor
Christian Opsahl Ross
Gina Butuc Steluta
Original Assignee
Nouryon Chemicals Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nouryon Chemicals Int Bv filed Critical Nouryon Chemicals Int Bv
Publication of PT3340975T publication Critical patent/PT3340975T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/327Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT167570183T 2015-08-28 2016-08-25 Formulação para o tratamento de acne PT3340975T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562211060P 2015-08-28 2015-08-28
EP15188210 2015-10-02

Publications (1)

Publication Number Publication Date
PT3340975T true PT3340975T (pt) 2019-11-04

Family

ID=56800291

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167570183T PT3340975T (pt) 2015-08-28 2016-08-25 Formulação para o tratamento de acne

Country Status (8)

Country Link
US (2) US10278945B2 (pt)
EP (1) EP3340975B1 (pt)
JP (1) JP6505945B2 (pt)
CN (1) CN107847479B (pt)
CA (1) CA2996095C (pt)
ES (1) ES2750873T3 (pt)
PT (1) PT3340975T (pt)
WO (1) WO2017036897A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019109828A1 (de) * 2019-04-12 2020-10-15 Biodermic Health & Beauty GmbH & Co KG Zusammensetzung zur topischen Anwendung auf der Haut

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2913220A1 (de) * 1979-04-03 1980-10-23 Bayer Ag Kalthaertendes material
FR2604435B1 (fr) * 1986-09-30 1988-12-02 Oreal Peroxydes aromatiques insatures et leur utilisation en therapeutique et cosmetique
DD298591A5 (de) * 1989-11-22 1992-03-05 Biologische Zentralanstalt Berlin,De Fungizide mittel
EP1183727A1 (en) * 2000-02-17 2002-03-06 Koninklijke Philips Electronics N.V. SEMICONDUCTOR DEVICE WITH AN INTEGRATED CMOS CIRCUIT WITH MOS TRANSISTORS HAVING SILICON-GERMANIUM (Si 1-x?Ge x?) GATE ELECTRODES, AND METHOD OF MANUFACTURING SAME
EA201290954A1 (ru) * 2010-03-25 2013-02-28 Сол-Джел Текнолоджиз Лтд. Композиция для топического применения
EA031461B9 (ru) * 2013-11-21 2019-03-29 ДСМ АйПи АССЕТС Б.В. Термореактивные композиции порошковых покрытий, содержащие метилзамещенный бензоилпероксид

Also Published As

Publication number Publication date
CN107847479A (zh) 2018-03-27
US10278945B2 (en) 2019-05-07
JP6505945B2 (ja) 2019-04-24
US20190321329A1 (en) 2019-10-24
CA2996095C (en) 2023-08-15
CA2996095A1 (en) 2017-03-09
ES2750873T3 (es) 2020-03-27
WO2017036897A1 (en) 2017-03-09
BR112018003385A2 (pt) 2018-09-25
EP3340975B1 (en) 2019-07-24
US20190022050A1 (en) 2019-01-24
JP2018525409A (ja) 2018-09-06
EP3340975A1 (en) 2018-07-04
CN107847479B (zh) 2020-11-20

Similar Documents

Publication Publication Date Title
HK1247202A1 (zh) 用於治療癌症的化合物
HK1232147A1 (zh) 用於治療纖維化的賽尼克韋羅
IL250960B (en) Combined treatment of sinecriviroc for the treatment of leprosy
IL279627A (en) A method for treating depression
PL3261726T3 (pl) Kompozycja do leczenia trądziku
SI3122358T1 (sl) Kombinacije FGFR- in CMET-inhibitorjev za zdravljenje raka
IL259996A (en) Combinations for cancer treatment
GB201608885D0 (en) Treatment
HK1247558A1 (zh) 塞內可瑞偉洛克(cenicriviroc)用於治療纖維化
IL249502B (en) New therapeutic uses of benzylideneguanidine derivatives for the treatment of diseases caused by structurally abnormal proteins
PL3184492T3 (pl) Preparat antyseptyczny
EP3148556A4 (en) Skin treatment formulations
IL268728A (en) Formulations of cannabinoids for the treatment of acne
EP3226886A4 (en) Use of fibulin-5 for the treatment of keloid scars
EP3200795A4 (en) Use of agents for treating fat-related disorders
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia
PT3340975T (pt) Formulação para o tratamento de acne
IL255167A0 (en) Compounds for the treatment of cancer
PL3164110T3 (pl) Kompozycje farmaceutyczne do leczenia łuszczycy
PT3524255T (pt) Composição para o tratamento do acne
ZA201704589B (en) Compounds for the treatment of cancer
GB201617107D0 (en) Treatment
GB201612260D0 (en) Treatment
GB201612193D0 (en) Treatment
GB201609683D0 (en) Treatment